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INTRODUCTION
Hyperhidrosis is a condition characterized by excessive
sweating and can be focal (primary) or generalized (secondary)
(1). Secondary hyperhidrosis is caused by an underlying condi-
tion such as infection, endocrine or metabolic disorders, neo-
plastic diseases, neurologic conditions, spinal cord injuries,
cardiovascular or respiratory disorders, anxiety, or stress (2, 3).
Primary hyperhidrosis has been associated with hyperac-
tivity of the sympathetic nervous system and can affect the
palms, soles, axillae, face, and scalp as well as other sites (2,
4). This condition occurs in otherwise healthy people and
can have a deeply detrimental effect on quality of life, result-
ing in impairment of daily activities, social interactions and
occupational activities (5, 6).
A pilot study of young Israelis reported an incidence of
1% (7), and hyperhidrosis prevalence in the United States is
2.8%, equivalent to 7.8 million people (2). Hyperhidrosis is
uncommon but not rare. Despite many treatment modalities,
research into the characteristics of hyperhidrosis patients is
limited. Here, we retrospectively investigated the epidemi-
ologic characteristics of primary hyperhidrosis patients vis-
iting a hyperhidrosis center in Korea.
MATERIALS AND METHODS
We reviewed the medical records of patients visiting our
hyperhidrosis center between March 2006, and February 2008,
for diagnosis and treatment of hyperhidrosis. Information
collected from the medical records included: sex, age at visit,
age of onset, referral source, occupation, family history, past
treatment, hyperhidrosis sites, aggravating factors and hyper-
hidrosis disease severity scale (HDSS) ranking. We analyzed
the relationship between family history of hyperhidrosis and
age of onset. Qualitative variables are expressed as percentages
and compared using Pearson’s chi-square test. Quantitative
variables are expressed as mean±standard deviation and com-
pared using Student’s t-test. We analyzed the results with
SPSS version 15.0 (SPSS, Chicago, IL, USA) and all Pvalues
less than 0.05 were considered statistically significant.
RESULTS
A total of 255 medical records were reviewed; 57.6% of the
patients were male, the mean age was 28.54±13.44 yr old at
the date of visit, with a mean age of onset of 15.0±8.78 yr
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An Epidemiological Study of Hyperhidrosis Patients Visiting  
the Ajou University Hospital Hyperhidrosis Center in Korea
Hyperhidrosis is a disorder of perspiration in excess of the body’s physiologic need
and significantly impacts one’s occupational, physical, emotional, and social life. The
purpose of our study was to investigate the characteristics of primary hyperhidrosis
in 255 patients at Ajou University Hospital Hyperhidrosis Center from March 2006,
to February 2008. Information collected from the medical records was: sex, sites
of hyperhidrosis, age at visit, age of onset, aggravating factors, hyperhidrosis dis-
ease severity scale (HDSS) rank, family history, occupation, and past treatment. A
total of 255 patient records were reviewed; 57.6% were male. Patients with a fami-
ly history (34.1%) showed a lower age of onset (13.21±5.80 yr vs. 16.04±9.83 yr
in those without family history); 16.5% had previous treatment, most commonly ori-
ental medicine. Palmar and plantar sites were the most commonly affected, and
87.9% of patients felt their sweating was intolerable and always interfered with their
daily activities. Our study provides some original information on the Korean primary
hyperhidrosis population. Patients who have a family history show signs of disease
in early age than those without family history.
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old, and 34.1% of all patients had a positive family history of
hyperhidrosis (Table 1). The mean age of onset in those with a
positive family history was 13.21±5.80 yr, significantly lower
than the age (16.04±9.83 yr) in those without family history
of hyperhidrosis (P<0.006).
The route to visit our center and occupation of the patients
are described by frequency (Tables 2, 3). The most common
route of visit was “arranged by individual clinic” and the most
common occupational category was “student”. Previous treat-
ment was attempted by 42 of the 255 patients (16.5%). The
most common treatment modality before the visit was ori-
ental medicine such as herbal medication and acupuncture
(Table 4). The most common aggravating factors were stress
or anxiety, and social relationships (Table 5). 
Palmar and plantar sites were the most commonly affected
sites (Fig. 1). We determined how hyperhidrosis affected their
life using the hyperhidrosis disease severity scale. Most (87.9%)
patients felt their sweating was intolerable and always inter-
feres with their daily activities (Fig. 2).
Demographics n=255 %
Sex
Male 147/255 57.6
Age at visit to our clinic (yr) 28.54±13.44
Mean±SD (yr) 
Male 27.38±13.03 
Female 30.12±13.87 
Age of onset (yr) 15.0±8.78
Mean±SD (yr)
Male 14.65±8.52 
Female 15.47±9.15 
Family history
Positive 164 34.1
Negative 87 64.3
Unaware 4 1.6
Table 1. Patient demographic data
Route  of  visit  % (n=255)
By Clinic  37.7
By Internet  27.0
By TV, newspapers and radios  16.3
By Recommendation from colleague  10.3
Other 8.7
Table 2. Referral source
Occupation  % (n=255)
Student (elementary, high school, college, or graduate)  51.8
Officer worker  14.5
Home (housewives, at-home mothers, homemakers)  14.1
Professional (teachers, engineers, physicians,  9
public service personnel) 
Unemployed 5.5
Self-employed 5.1
Table 3. Patient occupation
Past treatment received n=42 %
Oriental medicine  17 40.5
Surgery 13 30.9
Nerve block  5 11.9
Botulinum toxin type A  3 7.1
Topical aluminum chloride  2 4.8
Oral anticholinergics  2 4.8
Iontophoresis 0 0
Table 4. Previous treatment
Factors % 
Anxiety or stress  95.2 
Social relationships 77.0
Heat 52.4
Summer season 50.8
Winter season  13.7 
Exercise 10.1 
Take a meal  8.2 
Movement 7.3 
Writing under stressful conditions (e.g. an exam) 6.7 
Humidity 1.6 
Coffee or Caffeine  1.6 
Cold 0.8 
Table 5. Aggravating factors
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Fig. 1. Sites of hyperhidrosis. Others are any combinations of ex-
cessive sweating sites except palmar/platar and palmar/plantar/
axillae.774 E.J. Park, K.R. Han, H. Choi, et al.
DISCUSSION
This research provides original information on primary
hyperhidrosis and is the first descriptive study of Korean
hyperhidrosis patients. The average age of onset is 15.0 yr old
in our study, earlier than in a 2004 United States prevalence
study (25.2 yr) (2). However, a more recent US study in 2007
showed a similar average age of onset to our study (14.05 yr)
(8); the mean age at first visit for diagnosing and treatment
of hyperhidrosis was 28.05 yr in our study and also in the
recent US study (8), compared to 39.8 yr in the 2004 study
(2). These studies showed that primary hyperhidrosis appeared
in adolescence, but people seek medical treatment in early
adulthood. Stolman suggested a genetic predisposition may
exist, since 30-50% of patients have a family history of hyper-
hidrosis (9). A pedigree analysis by Kaufmann et al. (10) sug-
gested that hyperhidrosis segregated independently as an
autosomal dominant trait and was not inherited as a cross-
linked trait. Ro et al. (11) reported a 65% incidence of posi-
tive family history in 49 patients with hyperhidrosis that had
undergone thoracoscopic sympathectomy. The 2007 US study
showed 47.3% of hyperhidrosis patients had a positive fam-
ily history and patients who reported an onset age below 20
yr of age were more likely to have a positive family history
of hyperhidrosis than those with a later age of onset (8). In
line with these results, our study revealed a family history
in 34.1% of primary hyperhidrosis cases; and positive fami-
ly history patients had a younger onset age than those with
a negative family history (13.21±5.80 yr old vs. 16.04±
9.83 yr old).
Hyperhidrosis is present in 2.8% of the general population
in the United States (2). This condition can have a deeply detri-
mental effect on a patient’s quality of life, resulting in dra-
matic impairments of daily activities, social interactions and
occupational activities (5, 6). But, patients rarely seek a physi-
cian because many are unaware there are many treatments for
primary hyperhidrosis (1). In this study we asked patients how
they were referred to our hyperhidrosis clinic or how they got
information for hyperhidrosis treatment. The most common
referral mode was recommendation by individual clinics,
although many patients also found information from the inter-
net or mass media.
Lear et al. (8) reported patients had some form of treatment
before the consult visit, such as topical aluminum chloride or
botulinum toxin type A subcutaneous injections. However,
in this study the most common treatment modality before
the visit was oriental medicine such as herbal medication and
acupuncture. 
Hyperhidrosis can be generalized, involving the whole body,
but primary focal hyperhidrosis involves limited body areas,
most often palms, soles, face, axillae or a combination of them.
In our study, the most commonly affected sites that had exces-
sive sweating were palmar and plantar sites simultaneously
(32.2%). Other common sites were a combination of palmar,
plantar and axillae (22.4%). There are many treatment modal-
ities for hyperhidrosis such as topical aluminum chloride, ion-
tophoresis, botulinum toxin type A injection, endoscopic tho-
racic sympathectomy (ETS), axillary sweat gland removal,
oral anticholinergic, and chemical lumbar sympathectomy
(CLS) (12-15). Most of such treatment modalities are usual-
ly effective for focal area. But our results showed many pati-
ents suffer from excessive sweating in multiple sites. In our
clinic, We are performing different procedure depending on
problem area. Patients who has only palmar hyperhidrosis,
we perform VATS. Patients who has only plantar hyperhidro-
sis, we perform CLS. Patients who has only axillary hyper-
hidrosis, we perform axillary sweat gland removal. We use
oral anticholinergic (glycopyrrolate) for the patients who has
multiple sites hyperhidrosis or refuse to have invasive proce-
dure, contraindication to have invasive treatment, recurrence
after above mentioned procedure such as ETS, CLS, and axil-
lary sweat gland removal.
Excessive sweating of primary hyperhidrosis patients is usu-
ally triggered by anxiety, embarrassment, fear, anger, excite-
ment, or mental stress (16). Eccrine sweat glands are inner-
vated by cholinergic fibers from the sympathetic nervous sys-
tem. Their sweat secretion function is affected by emotional
and gustatory stimuli. Nearly all (95%) primary hyperhidro-
sis patients said their sweating was intensified when they were
in stressful situations or felt anxiety, and 77.0% felt their sym-
ptoms were aggravated in social situations. Another common
trigger factor was heat.
The severity and impact of hyperhidrosis was assessed using
the HDSS, which provides a qualitative measure allowing
tailored treatment; this validated and reliable instrument
has been used in other studies of hyperhidrosis (17, 18). The
HDSS is used to determine the severity of sweating experi-
enced by the respondents. A 4-point, single-item question,
the HDSS asks patients to indicate which of the following
best describes the impact of sweating on their daily activi-
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Fig. 2. Impact of sweating on daily activities accounting by hyper-
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ties: 1) never noticeable, never interferes; 2) tolerable, some-
time interferes; 3) barely tolerable, frequently interferes; or
4) intolerable and always interferes. Most (87.9%) of hyper-
hidrosis patients have sweating that is a ‘4’.
In conclusion, we described the epidemiologic character-
istics of primary hyperhidrosis patients in Korea for the first
time. These characteristics can help physicians who treat the
patients. The patients who have a family history show signs
of disease in early age than those without family history. Most
of hyperhidrosis patients have intolerable sweating and exces-
sive sweating which interfered their daily activities. Since the
study scope was limited to one hyperhidrosis center; a nation-
al survey should be performed to further expand the data
available to assist whole Korean patients.
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